Yang Yi,Liu Xin.Recent advances in the treatment of bladder/prostate rhabdomyosarcoma in children[J].Journal of Clinical Pediatric Surgery,,21():1101-1105.[doi:10.3760/cma.j.cn101785-202206005-001]
Recent advances in the treatment of bladder/prostate rhabdomyosarcoma in children
- Keywords:
- Rhabdomyosarcoma; Radiotherapy; Drug Therapy; Urogenital Surgical Procedures; Pathology; Surgical; Child
- Abstract:
- Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults, with bladder/prostate rhabdomyosarcoma being identified in 5% of cases.The overall survival for children with RMS has improved over the last five decades with multi-modal treatment. However,little progress has been made in the treatment of high-risk group children,whose outcomes remain poor despite aggressive multimodal treatment. In addition,as more patients survive longer,how to improve the quality of life of children and reduce short-term and long-term complications are also clinical challenge to be faced. Due to the different levels of medical treatment in various regions,the overall survival rate of children with rhabdomyosarcoma in China is still different from the international standard. In order to improve the recognition of pediatric urologists on the disease,this article describes the progress in the treatment of bladder/prostate rhabdomyosarcoma in children.
References:
[1] Rhee DS,Rodeberg DA,Baertschiger RM,et al.Update on pediatric rhabdomyosarcoma:a report from the APSA Cancer Committee[J].J Pediatr Surg,2020,55(10):1987-1995.DOI:10.1016/j.jpedsurg.2020.06.015.
[2] Saltzman AF,Cost NG.Current treatment of pediatric bladder and prostate rhabdomyosarcoma[J].Curr Urol Rep,2018,19(1):11.DOI:10.1007/s11934-018-0761-8.
[3] Hays DM,Raney RB,Wharam MD,et al.Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy,with or without radiotherapy.A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee[J].J Pediatr Hematol Oncol,1995,17(1):46-52.DOI:10.1097/00043426-199502000-00008.
[4] Castagnetti M,Herbst KW,Esposito C.Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs.radical cystectomy)[J].Curr Opin Urol,2019,29(5):487-492.DOI:10.1097/MOU.0000000000000651.
[5] Rodeberg DA,Anderson JR,Arndt CA,et al.Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate:combined results from the Children’s Oncology Group,German Cooperative Soft Tissue Sarcoma Study,Italian Cooperative Group,and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee[J].Int J Cancer,2011,128(5):1232-1239.DOI:10.1002/ijc.25444.
[6] Dantonello TM,Int-Veen C,Winkler P,et al.Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma[J].J Clin Oncol,2008,26(3):406-413.DOI:10.1200/JCO.2007.12.2382.
[7] Chargari C,Haie-Meder C,Guérin F,et al.Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma[J].Int J Radiat Oncol Biol Phys,2017,98(2):352-359.DOI:10.1016/j.ijrobp.2017.02.026.
[8] Schmidt A,Warmann SW,Eckert F,et al.The role of reconstructive surgery and brachytherapy in pediatric bladder/prostate rhabdomyosarcoma[J].J Urol,2020,204(4):825-834.DOI:10.1097/JU.0000000000001127.
[9] Lobo S,Gaze MN,Slater O,et al.Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma[J].Pediatr Blood Cancer,2022,69(8):e29574.DOI:10.1002/pbc.29574.
[10] Stenman J,Wickart-Johansson G,Sundquist F,et al.Five-year follow-up after multimodal treatment incorporating HDR brachytherapy for bladder prostate rhabdomyosarcoma in children[J].Int J Radiat Oncol Biol Phys,2022,113(2):355-359.DOI:10.1016/j.ijrobp.2022.01.034.
[11] Indelicato DJ,Rotondo RL,Krasin MJ,et al.Outcomes following proton therapy for group Ⅲ pelvic rhabdomyosarcoma[J].Int J Radiat Oncol Biol Phys,2020,106(5):968-976.DOI:10.1016/j.ijrobp.2019.12.036.
[12] Buszek SM,Ludmir EB,Grosshans DR,et al.Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma[J].Pediatr Blood Cancer,2019,66(11):e27952.DOI:10.1002/pbc.27952.
[13] Michalkiewicz EL,Rao BN,Gross E,et al.Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma[J].J Pediatr Surg,1997,32(9):1277-1282.DOI:10.1016/s0022-3468(97)90301-8.
[14] Stein R,Frees S,Schr?der A,et al.Radical surgery and different types of urinary diversion in patients with rhabdomyosarcoma of bladder or prostate-a single institution experience[J].J Pediatr Urol,2013,9(6 Pt A):932-939.DOI:10.1016/j.jpurol.2013.01.008.
[15] Castagnetti M,Angelini L,Alaggio R,et al.Oncologic outcome and urinary function after radical cystectomy for rhabdomyosarcoma in children:role of the orthotopic ileal neobladder based on 15-year experience at a single center[J].J Urol,2014,191(6):1850-1855.DOI:10.1016/j.juro.2013.12.040.
[16] Rigamonti W,Iafrate M,Milani C,et al.Orthotopic continent urinary diversion after radical cystectomy in pediatric patients with genitourinary rhabdomyosarcoma[J].J Urol,2006,175(3):1092-1096.DOI:10.1016/S0022-5347(05)00401-5.
[17] Komasara L,Stefanowicz J,Bryks-Laszkowska A,et al.Reconstructive option after radical mutilating surgery in children with genitourinary rhabdomyosarcoma:when sparing the bladder is not an option[J].Int J Urol,2016,23(8):679-685.DOI:10.1111/iju.13120.
[18] 中华医学会小儿外科学分会泌尿学组.膀胱/前列腺横纹肌肉瘤专家共识[J].临床小儿外科杂志,2019,18(11):902-905,921.DOI:10.3969/j.issn.1671-6353.2019.11.002.Group of Urology,Branch of Pediatric Surgery,Chinese Medical Association.Bladder/Prostate Rhabdomyosarcoma Expert Consensus[J].J Clin Ped Sur,2019,18(11):902-905,921.DOI:10.3969/j.issn.1671-6353.2019.11.002.
[19] Merguerian PA,Cartwright L,Khoury AE.Genitourinary rhabdomyosarcoma and other bladder tumors[M]//Docimo SG,Austin P,Canning D,et al.The Kelalis-King-Belman Textbook of Clinical Pediatric Urology.6th Ed.London:CRC Press,2018:1000-1028.
[20] Ben Arush M,Minard-Colin V,Mosseri V,et al.Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?[J].Eur J Cancer,2015,51(2):193-201.DOI:10.1016/j.ejca.2014.11.009.
[21] Mohan AC,Venkatramani R,Okcu MF,et al.Local therapy to distant metastatic sites in stage Ⅳ rhabdomyosarcoma[J].Pediatr Blood Cancer,2018,65(2):26859.DOI:10.1002/pbc.26859.
[22] Rodeberg D,Arndt C,Breneman J,et al.Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV[J].J Pediatr Surg,2005,40(1):256-262.DOI:10.1016/j.jpedsurg.2004.09.045.
[23] Cameron AL,Elze MC,Casanova M,et al.The impact of radiation therapy in children and adolescents with metastatic rhabdomyosarcoma[J].Int J Radiat Oncol Biol Phys,2021,111(4):968-978.DOI:10.1016/j.ijrobp.2021.06.031.
Memo
收稿日期:2022-6-4。
通讯作者:杨屹,Email:18940251106@163.com